tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Regeneron price target raised to $742 from $630 at Baird
PremiumThe FlyRegeneron price target raised to $742 from $630 at Baird
21d ago
Regeneron price target raised to $865 from $750 at Oppenheimer
Premium
The Fly
Regeneron price target raised to $865 from $750 at Oppenheimer
21d ago
Regeneron announces upcoming presentations at Angiogenesis annual meeting
Premium
The Fly
Regeneron announces upcoming presentations at Angiogenesis annual meeting
21d ago
Regeneron’s Earnings Call: Growth Engines and Rising Costs
PremiumCompany AnnouncementsRegeneron’s Earnings Call: Growth Engines and Rising Costs
24d ago
Regeneron Pharmaceuticals: Robust 4Q25 Beat, Underappreciated Pipeline Upside, and 2026 Catalysts Support Buy Rating and $870 Target
Premium
Ratings
Regeneron Pharmaceuticals: Robust 4Q25 Beat, Underappreciated Pipeline Upside, and 2026 Catalysts Support Buy Rating and $870 Target
24d ago
Regeneron price target raised to $870 from $820 at Raymond James
Premium
The Fly
Regeneron price target raised to $870 from $820 at Raymond James
24d ago
Regeneron: Earnings Reacceleration, Eylea HD and Dupixent Upside Drive Raised $916 Target and Outperform Rating
PremiumRatingsRegeneron: Earnings Reacceleration, Eylea HD and Dupixent Upside Drive Raised $916 Target and Outperform Rating
27d ago
Regeneron price target raised to $916 from $911 at Bernstein
Premium
The Fly
Regeneron price target raised to $916 from $911 at Bernstein
27d ago
Regeneron: Dupixent-Led Growth, EYLEA Franchise Stabilization, and High-Value Pipeline Catalysts Underpin Buy Rating
Premium
Ratings
Regeneron: Dupixent-Led Growth, EYLEA Franchise Stabilization, and High-Value Pipeline Catalysts Underpin Buy Rating
28d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100